Your browser doesn't support javascript.
loading
Polyvinyl alcohol coating prevents platelet adsorption and improves mechanical property of polycaprolactone-based small-caliber vascular graft.
Wakabayashi, Naohiro; Yoshida, Takumi; Oyama, Kyohei; Naruse, Daisuke; Tsutsui, Masahiro; Kikuchi, Yuta; Koga, Daisuke; Kamiya, Hiroyuki.
Afiliação
  • Wakabayashi N; Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Yoshida T; Life Materials Development Section, Human Life Technology Research Institute, Toyama Industrial Technology Research and Development Center, Toyama, Japan.
  • Oyama K; Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Naruse D; Business Development Section, Department of Business Development and Quality Control, Iaazaj Holdings Co., Ltd., Toyama, Japan.
  • Tsutsui M; Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kikuchi Y; Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Koga D; Department of Microscopic Anatomy and Cell Biology, Asahikawa Medical University, Asahikawa, Japan.
  • Kamiya H; Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan.
Front Cardiovasc Med ; 9: 946899, 2022.
Article em En | MEDLINE | ID: mdl-36035951
The low patency of synthetic vascular grafts hinders their practical applicability. Polyvinyl alcohol (PVA) is a non-toxic, highly hydrophilic polymer; thus, we created a PVA-coated polycaprolactone (PCL) nanofiber vascular graft (PVA-PCL graft). In this study, we examine whether PVA could improve the hydrophilicity of PCL grafts and evaluate its in vivo performance using a rat aorta implantation model. A PCL graft with an inner diameter of 1 mm is created using electrospinning (control). The PCL nanofibers are coated with PVA, resulting in a PVA-PCL graft. Mechanical property tests demonstrate that the PVA coating significantly increases the stiffness and resilience of the PCL graft. The PVA-PCL surface exhibits a much smaller sessile drop contact angle when compared with that of the control, indicating that the PVA coating has hydrophilic properties. Additionally, the PVA-PCL graft shows significantly less platelet adsorption than the control. The proposed PVA-PCL graft is implanted into the rat's abdominal aorta, and its in vivo performance is tested at 8 weeks. The patency rate is 83.3% (10/12). The histological analysis demonstrates autologous cell engraftment on and inside the scaffold, as well as CD31/α-smooth muscle positive neointima regeneration on the graft lumen. Thus, the PVA-PCL grafts exhibit biocompatibility in the rat model, which suggests that the PVA coating is a promising approach for functionalizing PCL.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça